Wakefield Asset Management LLLP
Position in ANIP — Ani Pharmaceuticals Inc
CIK 1600435
Englewood, CO
Position in ANIP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,186,982
+$104,384 QoQ
Shares Held
14,339
+1.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#133
of 303 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Wakefield Asset Management LLLP holds $2,719,173 across 3 Drug Manufacturers - Specialty & Generic names. ANIP ranks #1 (43.7% of the industry book) .
All Filings in ANIP
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,186,982 | 14,339 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,082,598 | 14,078 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,100,265 | 13,938 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $1,273,148 | 13,899 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,116,297 | 17,108 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,154,753 | 17,248 | Shares | Defined | 2025-05-06 | |
| 2024-09-30 | $824,441 | 13,819 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $890,628 | 13,986 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $979,088 | 14,163 | Shares | Defined | 2024-05-01 | |
| 2023-09-30 | $717,041 | 12,350 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $940,679 | 17,475 | Shares | Defined | 2023-08-01 | |
| No filing history on record for this holder in this stock. | ||||||